Where I see patients (1)
My reviews
Selected research
-
Microfluidics-free single-cell genomics with templated emulsification.
Nature biotechnology
-
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib.
Blood cancer journal
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9